BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24489795)

  • 1. Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.
    Ben-Dov IZ; Tan YC; Morozov P; Wilson PD; Rennert H; Blumenfeld JD; Tuschl T
    PLoS One; 2014; 9(1):e86856. PubMed ID: 24489795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease.
    Ali H; Malik MZ; Abu-Farha M; Abubaker J; Cherian P; Nizam R; Jacob S; Bahbahani Y; Naim M; Ahmad S; Al-Sayegh M; Thanaraj TA; Ong ACM; Harris PC; Al-Mulla F
    J Gene Med; 2024 Feb; 26(2):e3674. PubMed ID: 38404150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease.
    Magayr TA; Song X; Streets AJ; Vergoz L; Chang L; Valluru MK; Yap HL; Lannoy M; Haghighi A; Simms RJ; Tam FWK; Pei Y; Ong ACM
    Kidney Int; 2020 Aug; 98(2):420-435. PubMed ID: 32622528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary MicroRNAs, Possible Biomarkers for Early Detection of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
    Ghasemi Y; Mardomi A; Alizadeh E; Khosroshahi HT
    Iran J Kidney Dis; 2023 Mar; 1(2):73-78. PubMed ID: 37060340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.
    Zheng D; Wolfe M; Cowley BD; Wallace DP; Yamaguchi T; Grantham JJ
    J Am Soc Nephrol; 2003 Oct; 14(10):2588-95. PubMed ID: 14514736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiny Non-coding RNAs in Body Fluids, Possible Biomarkers for Autosomal Dominant Polycystic Kidney Disease.
    Ghasemi Y; Tayebi-Khosroshahi H; Abedi B; Rahmati-Yamchi M; Alizadeh E
    Iran J Kidney Dis; 2019 May; 13(3):151-164. PubMed ID: 31209188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.
    Sun L; Zhu J; Wu M; Sun H; Zhou C; Fu L; Xu C; Mei C
    Med Sci Monit; 2015 Jan; 21():195-200. PubMed ID: 25588980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).
    Norman J
    Biochim Biophys Acta; 2011 Oct; 1812(10):1327-36. PubMed ID: 21745567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring.
    Rauniyar N; Yu X; Cantley J; Voss EZ; Belcher J; Colangelo CM; Stone KL; Dahl N; Parikh C; Lam TT; Cantley LG
    Proteomics Clin Appl; 2018 Sep; 12(5):e1700157. PubMed ID: 29573172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of miR-192 and miR-194 on cyst enlargement through EMT in autosomal dominant polycystic kidney disease.
    Kim DY; Woo YM; Lee S; Oh S; Shin Y; Shin JO; Park EY; Ko JY; Lee EJ; Bok J; Yoo KH; Park JH
    FASEB J; 2019 Feb; 33(2):2870-2884. PubMed ID: 30332302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
    Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
    Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.
    Kawano H; Muto S; Ohmoto Y; Iwata F; Fujiki H; Mori T; Yan L; Horie S
    Clin Exp Nephrol; 2015 Oct; 19(5):968-73. PubMed ID: 25543187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
    Leierer J; Perco P; Hofer B; Eder S; Dzien A; Kerschbaum J; Rudnicki M; Mayer G
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
    van Heugten MH; Blijdorp CJ; Arjune S; van Willigenburg H; Bezstarosti K; Demmers JAA; Musterd-Bhaggoe U; Meijer E; Gansevoort RT; Zietse R; Hayat S; Kramann R; Müller RU; Salih M; Hoorn EJ;
    J Am Soc Nephrol; 2024 Mar; 35(3):321-334. PubMed ID: 38073039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease.
    Patel V; Williams D; Hajarnis S; Hunter R; Pontoglio M; Somlo S; Igarashi P
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10765-70. PubMed ID: 23759744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results.
    Griffin BR; You Z; Noureddine L; Gitomer B; Perrenoud L; Wang W; Chonchol M; Jalal D;
    Am J Nephrol; 2020; 51(6):473-479. PubMed ID: 32541154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.
    Yheskel M; Lakhia R; Cobo-Stark P; Flaten A; Patel V
    Sci Rep; 2019 Feb; 9(1):1920. PubMed ID: 30760828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.